Glaxosmithkline Phar Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue increased significantly in the latest quarter, reaching ₹1,010.77 Crore, marking a strong growth compared to previous quarters.
Net profit surged to ₹252.50 Crore in the last quarter, indicating improved profitability and operational efficiency.
Operating profit margin improved consistently, achieving 30.13% in the latest quarter, showcasing effective cost management.

NEGATIVES

Despite strong revenue growth, expenses also rose, particularly material costs, which could pressure future margins.
The profit before tax showed fluctuations, highlighting potential instability in earnings across the quarters.
Net profit dropped sharply to ₹45.72 Crore in Q3 2023, raising concerns about consistency in profitability.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	787.45	761.66	956.99	805.26	929.80	814.65	1,010.77	949.42	974.37	805.17
Expenses	617.71	617.78	667.50	587.20	672.54	584.11	689.06	657.50	641.18	553.97
Operating Profit	169.74	143.88	289.49	218.06	257.26	230.54	321.71	291.92	333.19	251.20
Other Income	27.66	36.44	28.21	28.11	29.83	35.64	34.54	35.07	40.68	43.72
Interest	0.65	0.28	0.43	0.32	0.77	0.37	0.27	0.09	0.58	0.42
Depreciation	17.18	16.36	18.11	17.11	18.10	16.41	16.86	18.80	14.72	15.52
Profit Before Tax	189.97	180.98	299.16	65.43	270.62	249.40	343.81	308.10	358.57	278.98
Tax	56.54	48.73	81.65	19.71	76.14	67.07	91.31	78.22	95.70	73.97
Net Profit	133.43	132.25	217.51	45.72	194.48	182.33	252.50	229.88	262.87	205.01
Eps in Rs	7.88	7.81	12.84	2.70	11.48	10.76	14.91	13.57	15.52	12.10